Sign In
Buy IMRA
$17.45
-0.680 (-3.75%)
At Close: Jun 03, 2026
Imara Announces the Appointment of Lynette Hopkinson as Senior Vice President of Regulatory
07:00am, Tuesday, 17'th Nov 2020
Brings 25 years of experience in the pharmaceutical and biotech industries and a deep understanding of global regulatory strategy and commercial regulatory affairs Brings 25 years of experience in the
IMARA Inc.'s (IMRA) CEO Rahul Ballal on Q3 2020 Results - Earnings Call Transcript
10:36am, Saturday, 07'th Nov 2020
IMARA Inc.'s (IMRA) CEO Rahul Ballal on Q3 2020 Results - Earnings Call Transcript
Imara Reports Third Quarter 2020 Financial Results and Business Highlights
07:00am, Thursday, 05'th Nov 2020
Patient Dosing Underway in Phase 2b clinical trials of IMR-687 in sickle cell disease and beta-thalassemia
Imara to Webcast Conference Call of Third Quarter Financial Results
07:00am, Thursday, 29'th Oct 2020
BOSTON, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients sufferi
Thalassemia Treatment Market Size, 2020 Growth, Types, Trends, Size, Share and Top Key Players by Forecast Research 2025
10:52am, Tuesday, 06'th Oct 2020
Oct 06, 2020 (Heraldkeepers) --
Global Thalassemia Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025. Rise in...
U.S. IPO Week Ahead: No IPOs, But Plenty Of Potential Launches In The Short Holiday Week
01:14pm, Sunday, 06'th Sep 2020
Just one SPAC is scheduled for the week ahead. More SPACs may join the IPO calendar, and another wave of new filings will likely hit after Labor Day as well.
Wall Street Breakfast: The Week Ahead
04:42am, Sunday, 06'th Sep 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Stocks To Watch: Tech Reboots And Eyes On Lululemon, Peloton & GameStop
08:21am, Saturday, 05'th Sep 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
TG Therapeutics Umbralisib Development, And Other News: The Good, Bad And Ugly Of Biopharma
12:57pm, Friday, 14'th Aug 2020
TG Therapeutics reports development for Umbralisib. Mesoblast gets FDA nod for Ryoncil.
The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal
12:26pm, Friday, 14'th Aug 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 13) * Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) * Fulgent Genetics Inc (NASDAQ: FLGT) * GENMAB A/S/S ADR (NASDAQ: GMAB) * Halozyme Ther
IMARA Inc.'s (IMRA) CEO Rahul Ballal on Q2 2020 Results - Earnings Call Transcript
12:14pm, Friday, 14'th Aug 2020
IMARA Inc. (NASDAQ:IMRA) Q2 2020 Results Earnings Conference Call August 14, 2020, 08:30 AM ET Company Participants Rahul Ballal - Chief Executive Officer Michael Gray - Chief Financial and Chief Oper
Imara Reports Second Quarter 2020 Financial Results and Business Highlights
11:00am, Friday, 14'th Aug 2020
Initiated Phase 2b clinical trials of IMR-687 in sickle cell disease and beta-thalassemia; First patient dosed in Ardent Phase 2b sickle cell clinical trialReported Phase 2a interim safety and efficac
Imara Announces First Patient Dosed in Ardent Phase 2b Clinical Trial of IMR-687 in Sickle Cell Disease
08:01pm, Thursday, 13'th Aug 2020
Highly selective, potent, small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell diseaseBOSTON, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Imara I
Global Hemoglobinopathy Treatment Drugs Market to Surpass US$ 6.4 Billion by 2027, Says Coherent Market Insights
12:00am, Tuesday, 11'th Aug 2020
The global hemoglobinopathy treatment drugs market is projected to exhibit a CAGR of 8.4% during the forecast period (2020-2027).
